Literature DB >> 9690602

Study of haemostatic disorders in experimentally induced leishmaniasis in Beagle dogs.

J E Valladares1, R Ruiz De Gopegui, C Riera, J Alberola, M Gállego, Y Espada, M Portús, M Arboix.   

Abstract

Haemostatic alterations in dogs experimentally infected with Leishmania infantum were studied before and after therapy with meglumine antimonate. Haemostatic function tests including platelet count, collagen-induced platelet aggregation, prothrombin time, activated partial thromboplastin time, thrombin time, plasma fibrinogen determination, and serum fibrinogen/fibrin degradation products concentration were performed. In the course of infection and before treatment, moderate thrombocytopenia (P<0.00001), decreased collagen induced platelet aggregation (P=0.0003), prolonged thrombin time (P=0.0117) and increased fibrinogen/fibrin degradation products were observed. Statistically significant differences of plasma fibrinogen concentration, prothrombin time, and activated partial thromboplastin time were not encountered. Haemostatic parameters returned to normal values after therapy. The results indicate that Leishmania infection may impair haemostasis suggesting induction of disseminated intravascular coagulation (DIC), and that treating dogs in an early stage of infection may potentially avoid the possibility of developing an uncompensated DIC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690602     DOI: 10.1016/s0034-5288(98)90124-2

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  Haemostatic disorders in dogs naturally infected by Leishmania infantum.

Authors:  M Corona; P Ciaramella; A Pelagalli; L Cortese; M E Pero; D Santoro; P Lombardi
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

2.  Disseminated intravascular coagulation in a dog naturally infected by Leishmania (Leishmania) chagasi from Rio de Janeiro - Brazil.

Authors:  Carla O Honse; Fabiano B Figueiredo; Nayro X de Alencar; Maria de Fátima Madeira; Isabella D F Gremião; Tânia M P Schubach
Journal:  BMC Vet Res       Date:  2013-03-05       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.